Wu Clara Q, Lefebvre Guylaine, Frecker Helena, Husslein Heinrich
Department of Obstetrics, Gynecology & Reproductive Sciences, University of Saskatchewan, Regina, Saskatchewan, Canada.
Int Urogynecol J. 2015 Sep;26(9):1277-84. doi: 10.1007/s00192-015-2665-1. Epub 2015 Mar 10.
Uterine leiomyomas are underrecognized as a cause of acute urinary retention (AUR) in women. The objective of this study was to present a case series and systematic review of the literature, to elucidate the pathogenesis of leiomyoma-related AUR, and to suggest management strategies. We included patients presenting with AUR and uterine leiomyomas at our institution between January 2011 and December 2013. Further, we systematically searched the Cochrane Library (from 1898 to June 2014), EMBASE (from 1947 to June 2014), and MEDLINE (from 1946 to June 2014) databases according to the PRISMA guidelines. A total of six patients with AUR and leiomyomas presented to our institution. Through the systematic review, another 31 cases of AUR were identified. Combined patient ages ranged from 25 to 75 years. Uterine size ranged from 10 to 22 weeks on physical examination and from 5.5 to 26 cm on imaging. The dominant leiomyoma size ranged from 5.7 to 22.4 cm. Significant risk factors were posterior or fundal leiomyoma position and the presence of a retroverted uterus. Proposed mechanisms for leiomyoma-related AUR include proximal urethra or bladder-neck compression, premenstrual pelvic congestion, vascular steal effect, and compression of pudendal or sacral nerves. Patients were treated with hysterectomy, myomectomy, uterine fibroid embolization, hormones, or by conservative management alone. In the absence of neurologic disorders or other risk factors, neither urodynamic studies nor neuromuscular testing seem to contribute to diagnosis or guide management in women with uterine leiomyomas and AUR. Patients presenting to gynecologists seem to experience shorter times to diagnosis and treatment compared with other specialties. It is essential to recognize leiomyomas as a potential cause of AUR in order to reduce unnecessary testing and delays in diagnosis and management.
子宫平滑肌瘤作为女性急性尿潴留(AUR)的病因未得到充分认识。本研究的目的是呈现一个病例系列并对文献进行系统综述,以阐明平滑肌瘤相关AUR的发病机制,并提出管理策略。我们纳入了2011年1月至2013年12月期间在我们机构出现AUR和子宫平滑肌瘤的患者。此外,我们根据PRISMA指南系统检索了Cochrane图书馆(从1898年至2014年6月)、EMBASE(从1947年至2014年6月)和MEDLINE(从1946年至2014年6月)数据库。共有6例患有AUR和平滑肌瘤的患者到我们机构就诊。通过系统综述,又确定了31例AUR病例。患者的综合年龄范围为25至75岁。体格检查时子宫大小范围为10至22周,影像学检查时为5.5至26厘米。主要平滑肌瘤大小范围为5.7至22.4厘米。重要的危险因素是后壁或底部平滑肌瘤位置以及子宫后倾的存在。平滑肌瘤相关AUR的推测机制包括近端尿道或膀胱颈受压、经前期盆腔充血、血管盗血效应以及阴部神经或骶神经受压。患者接受了子宫切除术、肌瘤切除术、子宫纤维瘤栓塞术、激素治疗或仅采用保守治疗。在没有神经系统疾病或其他危险因素的情况下,尿动力学研究和神经肌肉测试似乎都无助于子宫平滑肌瘤合并AUR女性的诊断或指导治疗。与其他专科相比,向妇科医生就诊的患者似乎诊断和治疗时间更短。认识到平滑肌瘤是AUR的潜在病因对于减少不必要的检查以及诊断和治疗延迟至关重要。